ANTI-HYPERCHOLESTEROLEMIC DRUG COMBINATION

Title:

ANTI-HYPERCHOLESTEROLEMIC DRUG COMBINATION

Document Type and Number:

WIPO Patent Application WO2002015845

Kind Code:

A3

Abstract:

This invention provides a drug combination comprised of a thyroid hormone receptor beta agonist with a fibrate in therapeutically effective amounts, which is useful for reducing cholesterol synthesis, lowering plasma cholesterol levels and lowering plasma triglyceride levels.

Inventors:

CHENG KANG (US)
WRIGHT SAMUEL D (US)
WU TSUEI-JU (US)

Application Number:

PCT/US2001/025815

Publication Date:

January 09, 2003

Filing Date:

August 17, 2001

Export Citation:

Click for automatic bibliography generation Help

Assignee:

MERCK & CO INC (US)
CHENG KANG (US)
WRIGHT SAMUEL D (US)
WU TSUEI-JU (US)

International Classes:

A61K31/192; A61K31/197; A61K31/198; A61K31/216; A61K45/06; A61P9/10; (IPC1-7): A61K31/24

Foreign References:

US5569674A	1996-10-29
US6090836A	2000-07-18
US5608084A	1997-03-04

Download PDF:

View/Download PDF PDF Help

Previous Patent: ANTIMICROBIAL COMPOSITION AND METHODS OF USE IN THE TREATMENT OF DISEASE

Next Patent: ANTI-RANK LIGAND MONOCLONAL ANTIBODIES USEFUL IN TREATMENT OF RANK LIGAND MEDIATED DISORDERS